Blueprint Medicines Statistics
Total Valuation
GEHC has a market cap or net worth of $32.25 billion. The enterprise value is $39.23 billion.
| Market Cap | 32.25B |
| Enterprise Value | 39.23B |
Important Dates
The last earnings date was Wednesday, July 30, 2025, before market open.
| Earnings Date | Jul 30, 2025 |
| Ex-Dividend Date | Jul 25, 2025 |
Share Statistics
GEHC has 456.56 million shares outstanding. The number of shares has increased by 0.11% in one year.
| Current Share Class | 456.56M |
| Shares Outstanding | 456.56M |
| Shares Change (YoY) | +0.11% |
| Shares Change (QoQ) | -0.22% |
| Owned by Insiders (%) | 0.16% |
| Owned by Institutions (%) | 78.15% |
| Float | 455.36M |
Valuation Ratios
The trailing PE ratio is 14.48 and the forward PE ratio is 15.21. GEHC's PEG ratio is 2.13.
| PE Ratio | 14.48 |
| Forward PE | 15.21 |
| PS Ratio | 1.62 |
| Forward PS | 1.53 |
| PB Ratio | 3.32 |
| P/TBV Ratio | n/a |
| P/FCF Ratio | 20.61 |
| P/OCF Ratio | 16.17 |
| PEG Ratio | 2.13 |
Enterprise Valuation
The stock's EV/EBITDA ratio is 10.68, with an EV/FCF ratio of 25.07.
| EV / Earnings | 17.51 |
| EV / Sales | 1.96 |
| EV / EBITDA | 10.68 |
| EV / EBIT | 12.63 |
| EV / FCF | 25.07 |
Financial Position
The company has a current ratio of 1.16, with a Debt / Equity ratio of 1.08.
| Current Ratio | 1.16 |
| Quick Ratio | 0.83 |
| Debt / Equity | 1.08 |
| Debt / EBITDA | 2.72 |
| Debt / FCF | 6.85 |
| Interest Coverage | 7.42 |
Financial Efficiency
Return on equity (ROE) is 25.80% and return on invested capital (ROIC) is 10.13%.
| Return on Equity (ROE) | 25.80% |
| Return on Assets (ROA) | 5.77% |
| Return on Invested Capital (ROIC) | 10.13% |
| Return on Capital Employed (ROCE) | 12.07% |
| Revenue Per Employee | $376,736 |
| Profits Per Employee | $42,264 |
| Employee Count | 53,000 |
| Asset Turnover | 0.59 |
| Inventory Turnover | 5.42 |
Taxes
In the past 12 months, GEHC has paid $480.00 million in taxes.
| Income Tax | 480.00M |
| Effective Tax Rate | 17.17% |
Stock Price Statistics
The stock price has decreased by -15.34% in the last 52 weeks. The beta is 1.28, so GEHC's price volatility has been higher than the market average.
| Beta (5Y) | 1.28 |
| 52-Week Price Change | -15.34% |
| 50-Day Moving Average | 73.44 |
| 200-Day Moving Average | 79.04 |
| Relative Strength Index (RSI) | 37.67 |
| Average Volume (20 Days) | 4,199,544 |
Short Selling Information
The latest short interest is 6.62 million, so 1.45% of the outstanding shares have been sold short.
| Short Interest | 6.62M |
| Short Previous Month | 7.88M |
| Short % of Shares Out | 1.45% |
| Short % of Float | 1.45% |
| Short Ratio (days to cover) | 1.72 |
Income Statement
In the last 12 months, GEHC had revenue of $19.97 billion and earned $2.24 billion in profits. Earnings per share was $4.88.
| Revenue | 19.97B |
| Gross Profit | 8.30B |
| Operating Income | 3.11B |
| Pretax Income | 2.29B |
| Net Income | 2.24B |
| EBITDA | 3.67B |
| EBIT | 3.11B |
| Earnings Per Share (EPS) | $4.88 |
Balance Sheet
The company has $3.74 billion in cash and $10.72 billion in debt, giving a net cash position of -$6.98 billion or -$15.29 per share.
| Cash & Cash Equivalents | 3.74B |
| Total Debt | 10.72B |
| Net Cash | -6.98B |
| Net Cash Per Share | -$15.29 |
| Equity (Book Value) | 9.95B |
| Book Value Per Share | 21.27 |
| Working Capital | 1.56B |
Cash Flow
In the last 12 months, operating cash flow was $2.00 billion and capital expenditures -$430.00 million, giving a free cash flow of $1.57 billion.
| Operating Cash Flow | 2.00B |
| Capital Expenditures | -430.00M |
| Free Cash Flow | 1.57B |
| FCF Per Share | $3.43 |
Margins
Gross margin is 41.56%, with operating and profit margins of 15.56% and 11.22%.
| Gross Margin | 41.56% |
| Operating Margin | 15.56% |
| Pretax Margin | 14.00% |
| Profit Margin | 11.22% |
| EBITDA Margin | 18.40% |
| EBIT Margin | 15.56% |
| FCF Margin | 7.84% |
Dividends & Yields
This stock pays an annual dividend of $0.14, which amounts to a dividend yield of 0.19%.
| Dividend Per Share | $0.14 |
| Dividend Yield | 0.19% |
| Dividend Growth (YoY) | 12.50% |
| Years of Dividend Growth | 2 |
| Payout Ratio | 2.77% |
| Buyback Yield | -0.11% |
| Shareholder Yield | 0.08% |
| Earnings Yield | 6.95% |
| FCF Yield | 4.85% |
Analyst Forecast
The average price target for GEHC is $89.10, which is 26.13% higher than the current price. The consensus rating is "Strong Buy".
| Price Target | $89.10 |
| Price Target Difference | 26.13% |
| Analyst Consensus | Strong Buy |
| Analyst Count | 10 |
| Revenue Growth Forecast (5Y) | 3.95% |
| EPS Growth Forecast (5Y) | 6.06% |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | |
| Lynch Upside | |
| Graham Number | |
| Graham Upside |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
GEHC has an Altman Z-Score of 1.94 and a Piotroski F-Score of 5. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | 1.94 |
| Piotroski F-Score | 5 |